Dentons Hong Kong has advised Goldman Sachs and Haitong International Capital on the initial public offering of Broncus Holding Corporation on the Hong Kong Stock Exchange under Chapter 18A of the Listing Rules. The offering is aimed at raising net proceeds of approximately US$191 million. Broncus is a leading interventional pulmonology medical device player in China and globally and has developed an integrated interventional pulmonology platform encompassing navigation, diagnosis and treatment, which addresses the pain points of the existing diagnosis and treatment paradigms.

The Dentons Hong Kong team is led by capital markets partner Gordon Ng and associate Ningxin Sun.

About Dentons

Across over 80 countries, Dentons helps you grow, protect, operate and finance your organization by providing uniquely global and deeply local legal solutions. Polycentric, purpose-driven and committed to inclusion, diversity, equity and sustainability, we focus on what matters most to you. www.dentons.com